We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Companies Pool Interests to Develop Toponomics Platform

By Biotechdaily staff writers
Posted on 30 Jan 2003
A collaborative agreement to develop a new technology platform for managing the analysis of protein networks of whole cells in situ, known as topologic proteomics or toponomics, has been announced by MelTec GmbH (Magdeburg, Germany) and the Fraunhofer Institute for Applied Information Technology (FIT, Sankt Augustin, Germany).

Under the agreement, the two companies will work together to develop new software-based approaches to analyze and visualize protein networks and then correlate that data with results from in vitro and in vivo experiments. They will combine the robotic toponomics imaging technology of MelTec with the image management and proteomics software of FIT. The system will be designed to rapidly produce high-quality results for understanding how proteins impact a drug's effectiveness.

"Our alliance will allow us to create an integrated environment that enables biologists to quickly identify and validate functional aspects of living cells,” said Dr. Thomas Berlage, director of FIT.




Related Links:
MelTec
Fraunhofer Institute for Applied Information Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Electrolyte Analyzer
BKE-B

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
30 Jan 2003  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
30 Jan 2003  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
30 Jan 2003  |   BioResearch